Robert Carey, MD, MACP

PRIMARY APPOINTMENT:

Professor of Medicine
Dean Emeritus, School of Medicine, University of Virginia
David A. Harrison III, Distinguished Professor of Medicine

CONTACT:

Robert M. Carey, MD, MACP
Professor of Medicine
Dean Emeritus, School of Medicine
University of Virginia School of Medicine
PO Box 801414, University of Virginia Health System
Charlottesville, VA 22908

Telephone: 434-924-5510
Fax: 434-982-3626
Email: rmc4C@virginia.edu

CLINICAL EXPERTISE:

Dr. Robert M. Carey is a world-renowned clinical endocrinologist and leader in cardiovascular endocrinology. He is a past recipient of the Distinguished Physician Award and the Outstanding Leadership Award of the Endocrine Society and was President of The Endocrine Society 2008-9.

Dr. Carey is a general clinical endocrinologist with expertise in the hormonal causes of high blood pressure, body fluid and electrolyte disturbances, and adrenal disorders. Throughout his career, Dr. Carey has provided clinical care in general endocrinology, cardiovascular endocrinology, adrenal disease, and hypertension.  He has particular expertise in the following areas: primary hypertension, drug-resistant hypertension, secondary hypertension, diabetes with hypertension, renovascular hypertension, hyperlipidemia, adrenal mass lesions, primary aldosteronism, pheochromocytoma, Cushing’s syndrome, adrenal insufficiency, congenital adrenal hyperplasia, hypokalemia, hyperkalemia, hyponatremia, syndrome of inappropriate vasopressin secretion, diabetes insipidus, carcinoid syndrome, and neuroendocrine tumors.

RESEARCH SUMMARY:

Dr. Carey’s research is focused on understanding the pathophysiologic mechanisms of hypertension. He is studying the function of dopamine and angiotensin receptors in the kidney, heart, and peripheral blood vessels. His laboratory has pioneered the discovery of the function of renal D1-like receptors and angiotensin AT-2 receptors. Current projects involve the role of AT-2 receptors in sodium excretion and hypertension, the interaction of dopamine receptors with angiotensin receptors within the kidney, and the role of extracellular renal cyclic GMP in pressure-natriuresis.

Research Funding

NIH/NHLBI R01 HL12818904 (1/1/2021 – 12/31/2024) NIH/NHLBI R01 HL168518 (1/1/2021 – 12/31/2025)

Collaborators

University of Virginia

• Robin A. Felder, Ph.D., Professor of Pathology and Director of the
  Medical Automation Research Center, University of Virginia
• John J. Gildea, Ph.D., Research Scientist, Department of Pathology,
  University of Virginia
• Susanna R. Keller, PhD, Associate Professor of Medicine, University of Virginia
• Helmy M. Siragy, M.D., Professor of Medicine, Division of
  Endocrinology and Metabolism, Department of Medicine, University of Virginia
• David L. Brautigan, PhD, Professor Emeritus of Pharmacology, University of Virginia
• R. Arial Gomez, M.D., University of Virginia
• Bijoy Kundu, PhD, Associate Professor of Radiology and Biomedical Imaging, University of Virginia

National

• Pedro A. Jose, MD, PhD, Professor of Medicine, Pharmacology and Physiology, George Washington University
• Adina F. Tuneu, MD, MS, Assistant Professor of Medicine, University of Michigan
• Gordon H. Williams, MD, Professor of Medicine, Harvard Medical School